B-CELL NON-HODGKINS LYMPHOMA

Clinical trials for B-CELL NON-HODGKINS LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new B-CELL NON-HODGKINS LYMPHOMA trials appear

Sign up with your email to follow new studies for B-CELL NON-HODGKINS LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New approach aims to tame side effects of potent lymphoma therapy

Disease control Recruiting now

This study is testing a three-drug combination for people with an aggressive type of B-cell lymphoma that has returned or not responded to prior treatment. The main goal is to see if a specific pre-treatment plan can better manage a common side effect called cytokine release synd…

Matched conditions: B-CELL NON-HODGKINS LYMPHOMA

Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

B-CELL NON-HODGKINS LYMPHOMA

Get alerted when new B-CELL NON-HODGKINS LYMPHOMA trials appear

New approach aims to tame side effects of potent lymphoma therapy